FDA Inspection 629464 — Servy Institute For Reproductive Endocrinology
The FDA completed an inspection of Servy Institute For Reproductive Endocrinology on Oct 30, 2009 in Augusta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 30, 2009
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Augusta, GA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12221 | 21 CFR 1271.47(a) | Procedures for all other requirements |
| 12444 | 21 CFR 1271.270(e) | Contract firms--identities and responsibilities |